Journal Article Summary
The article investigates a new formulation for delivering loratadine, an anti-allergic medication, through the nasal route. The study focuses on enhancing the drug's solubility and bioavailability by creating a complex with β-cyclodextrin and developing a thermally triggered mucoadhesive gel. This topic is significant because improving how medications are absorbed can lead to better treatment outcomes for patients suffering from allergies, as it helps to bypass the first-pass metabolism that can reduce the effectiveness of oral medications.
The researchers prepared and tested eight different formulations of the nasal gel using a systematic approach to optimize key ingredients, including poloxamer 407 and carbopol 934 P. They found that the formulation containing the loratadine-β-cyclodextrin complex allowed for faster drug absorption and better performance compared to the free drug. The best formulation achieved a gelling temperature of approximately 28.6°C and demonstrated strong mucoadhesive properties, with nearly 98% of the drug permeating through the nasal membrane within six hours. Additionally, the formulation remained stable for over three months and did not cause significant damage to nasal tissue during testing.
However, the study has limitations, including the need for further research to confirm long-term safety and effectiveness in humans. Patients should be aware that while this formulation shows promise, it is still in the experimental stage and not yet available for general use. It is essential for individuals to consult with healthcare professionals before considering new treatments, especially those involving novel drug delivery systems, to ensure safety and appropriateness for their specific health needs.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Singh Reena M. P., Kumar Anil, Pathak Kamla. Thermally Triggered Mucoadhesive In Situ Gel of Loratadine: β-Cyclodextrin Complex for Nasal Delivery. AAPS PharmSciTech 2013. DOI: 10.1208/s12249-013-9921-9. PMID: 23358934. PMCID: PMC3581637.
Featured Pill Pals Product
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major / Rugby
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
